Kyowa Kirin reports positive results from MAVORIC study
Japan-based Kyowa Hakko Kirin has reported positive results from the Mogamulizumab anti-CCR4 Antibody Versus ComparatOR...
Japan-based Kyowa Hakko Kirin has reported positive results from the Mogamulizumab anti-CCR4 Antibody Versus ComparatOR...